Información de la revista
Original article
Open Access
Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysis
Tratamientos basados en sofosbuvir en la infección por el VHC en la enfermedad renal crónica en estadio 4 o estadio 5. Una revisión sistemática con metaanálisis
Fabrizio Fabrizia,
, Roberta Ceruttia, Vivek Dixitb, Ezequiel Ridruejoc,d,e
Autor para correspondencia
a Division of Nephrology, Dialysis and Transplantation IRCCS Ca Granda Foundation and Maggiore Polyclynic Hospital, Milano, Italy
b Division of Digestive Diseases, UCLA School of Medicine, CA, USA
c Hepatology Section, Department of Medicine, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno “CEMIC”, Ciudad Autonoma de Buoenos Aires, Argentina
d Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Provincia de Buenos Aires, Argentina
e Latin American Liver Research, Educational and Awareness Network (LALREAN), Pilar, Provincia de Buenos Aires, Argentina
Artículo
This article is available in English
Sofosbuvir-based regimens for HCV in stage 4–stage 5 chronic kidney disease. A systematic review with meta-analysis
Fabrizio Fabrizi, Roberta Cerutti, Vivek Dixit, Ezequiel Ridruejo
10.1016/j.nefroe.2021.11.011Nefrologia (English Version). 2021;41:578-89